Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
64,968,404
-
Share change
-
+2,440,984
-
Total reported value
-
$1,066,709,124
-
Put/Call ratio
-
307%
-
Price per share
-
$16.30
-
Number of holders
-
101
-
Value change
-
+$34,858,183
-
Number of buys
-
44
-
Number of sells
-
44
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q3 2023
As of 30 Sep 2023,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,968,404 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., and FEDERATED HERMES, INC..
This page lists
101
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.